Serial #79111218
LIVE

Serial Number

79111218

Owner

Vela Holding Pte. Ltd

Attorney

Stacy L. Emhoff

Filing Date

Nov 17, 2011

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79111218 Trademark

Serial Number: 79111218 • Registration: 4303264

Serial #79111218 is a trademark filed by Vela Holding Pte. Ltd on November 17, 2011. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Vela Holding Pte. Ltd (4 trademarks)

#02-04/05/06 The Kendall

Entity Type: 99

Vela Diagnostics Holding Ptd Ltd. (2 trademarks)

50 Science Park Road,

Entity Type: 99

Trademark Details

Filing Date

November 17, 2011

Registration Date

March 19, 2013

Published for Opposition

January 1, 2013

Goods & Services

Teaching services in the field of medical diagnosis

Scientific apparatus and instruments for laboratory use, in particular for research and development purposes in the nature of thermocyclers for amplifying, and analyzing biopolymers, in particular nucleic acids and biologically active substances; scientific apparatus and instruments for scientific research, non-medical diagnostic analysis, chemical analysis, clinical analysis, namely, electrophoretic apparatuses, homogenizers for marking, separating, isolating, purifying, amplifying, and analyzing biopolymers, in particular nucleic acids, proteins macro molecules and biologically active substances, spectrophotometers for measuring relative DNA, RNA and protein; computer hardware; computer software for operation and maintenance of scientific apparatus, instruments and equipment, namely, for electrophoretic apparatuses, homogenizers, spectrophotometers and laboratory robots; computer software for creating experimental profiles and providing experimental reports based on sample preparation, modification and manipulation of cells as well as on synthesis, amplification, labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules; computer software for creating reports of apparatus performance verification, namely, for apparatuses for research and development purposes in the nature of thermocyclers for amplifying, and analyzing biopolymers, in particular nucleic acids and biologically active substances, and for apparatuses for non-medical diagnostic analysis, chemical analysis, clinical analysis, namely, electrophoretic apparatuses, homogenizers for marking, separating, isolating, purifying, amplifying, and analyzing biopolymers, in particular nucleic acids, proteins macro molecules and biologically active substances, spectrophotometers for measuring relative DNA, RNA and protein; computer software for analyzing, displaying and visualizing experimental data and biological data, namely, polymerase chain reaction data, Real-Time-polymerase chain reaction data, and electrophoresis data

Pharmaceutical and veterinary preparations, namely biological substances and chemicals used for medical scientific and medical research purposes, namely reagents and solvents for research, in particular for sample preparation, modification and manipulation of cells as well as for the performance of synthesis, amplification, labeling, separation, isolation, reproduction and purification methods for biopolymers, in particular nucleic acids, proteins, marcomolecules and biologically active substances; kits consisting primarily of protein assays and chemical reagents for medical scientific and medical research purposes, in particular for sample preparation, modification and manipulation of cells as well as for synthesis, amplification, labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules; in-vitro diagnostic preparations for medical purposes; sanitary preparations for medical purposes

Data processing services

Biological and chemical substances used in industry and for scientific and research purposes, namely diagnostic preparations, except for human medicine and veterinary medicine purposes; reagents and solvents for research and not for human medical and veterinary purposes, in particular for sample preparation, modification and manipulation of cells as well as for the performance of labeling, synthesis, amplification, separation, isolation, reproduction and purification methods for biopolymers, in particular nucleic acids, proteins, marcomolecules and biologically active substances; kits consisting primarily of nucleic acid assays and chemical reagents for research, except for human medicine and veterinary medicine purposes, in particular for sample preparation, modification and manipulation of cells as well as for synthesis, amplification, labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules

Medical consultations; consulting services in the field of health; medical services; health care services; medical clinics; medical care services

Medical apparatus and implements, namely apparatus and implements for the conducting and evaluation of clinical diagnostic examinations for medical purposes

Scientific and technological services and research services and scientific consultancy services in the field of scientific research, analysis and testing in the field of clinical, veterinary, environmental and medical diagnosis; development of computer hardware and software for the operation and maintenance of scientific apparatus, instruments and equipment; development of computer software for creating experimental profiles, providing experimental reports and reports of apparatus performance verification; development of computer software for analyzing, displaying and visualizing experimental data and biological data

Filing History

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
May 7, 2024 NA71
REGISTERED-SEC.71 ACCEPTED
May 7, 2024 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 4, 2023 APRE
TEAS SECTION 71 RECEIVED
Mar 7, 2023 ES71
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Mar 19, 2022 REM4
INTERNATIONAL REGISTRATION RENEWED
Dec 3, 2021 RNWL
NEW REPRESENTATIVE AT IB RECEIVED
Aug 27, 2021 NREP
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Mar 27, 2019 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Mar 27, 2019 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 19, 2019 APRE
TEAS SECTION 71 & 15 RECEIVED
Mar 11, 2019 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 19, 2018 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Feb 12, 2016 NREP
CHANGE OF OWNER RECEIVED FROM IB
Feb 12, 2016 CHLD
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 29, 2015 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 29, 2015 REAP
NEW REPRESENTATIVE AT IB RECEIVED
Feb 13, 2015 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 23, 2013 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 5, 2013 FICS
FINAL DISPOSITION PROCESSED
Nov 5, 2013 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 19, 2013 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 19, 2013 R.PR
NOTIFICATION PROCESSED BY IB
Jan 14, 2013 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 1, 2013 NPUB
PUBLISHED FOR OPPOSITION
Jan 1, 2013 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 12, 2012 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 12, 2012 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 12, 2012 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 28, 2012 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 21, 2012 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 21, 2012 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 21, 2012 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 21, 2012 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 21, 2012 CNEA
EXAMINER'S AMENDMENT ENTERED
Nov 21, 2012 XAEC
ASSIGNED TO LIE
Nov 21, 2012 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 21, 2012 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 21, 2012 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 21, 2012 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 31, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 29, 2012 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 29, 2012 TROA
REFUSAL PROCESSED BY IB
May 19, 2012 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 30, 2012 RFCS
REFUSAL PROCESSED BY MPU
Apr 30, 2012 RFRR
APPLICATION FILING RECEIPT MAILED
Apr 28, 2012 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 26, 2012 RFCR
NON-FINAL ACTION WRITTEN
Apr 25, 2012 CNRT
ASSIGNED TO EXAMINER
Apr 24, 2012 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 24, 2012 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Apr 23, 2012 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 21, 2012 REPR